• Join the Coalition against Typhoid, the Bangladesh Pediatric Association, Icddr,b and IVI on 1-2 March, 2013 in Dhaka, Bangladesh for the latest updates on research and public health agendas related to thyphoid fever.

    Register for the conference today!

     
  • Our Vision

    The Vi-based Vaccines for Asia Initiative (VIVA) is established to reduce typhoid fever mortality and morbidity in infants and children in typhoid endemic countries through accelerating the adoption of Vi vaccines and the technical development, clinical evaluation, licensure and sustainable introduction of affordable Vi conjugate vaccines.

     
  • Our Goal

    VIVA's goal is to reduce typhoid fever mortality and morbidity in infants and children in countries that are afflicted by typhoid through the accelerating adoption of existing typhoid vaccines (Vi polysaccharide vaccine), and by developing a new and affordable Vi conjugate vaccines.

     
  • Our Objectives

    VIVA undertakes a wide spectrum of multi-disciplinary activities from vaccine development to advocacy for the use of typhoid vaccines.

     
FEATURED STORIES / ACHIEVEMENTS


Talking with Dr. Christian Loucq, Director General, International Vaccine Institute
12 October, 2012   Read More...


RSS FEED


About our site

The Vi-based Vaccines for Asia Initiative, more commonly known as the VIVA Initiative, is a five-year program supported by the Bill & Melinda Gates Foundation and coordinated by the International Vaccine Institute (IVI).

PHOTO GALLERY

VIDEO